Curetis Announces New Supervisory Board of Curetis N.V.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Curetis Announces New Supervisory Board of Curetis N.V.

AMSTERDAM, The Netherlands and HOLZGERLINGEN, Germany, Oct. 29, 2015 (GLOBE NEWSWIRE) -- Curetis B.V. 1 (" Curetis "), a developer of next-level molecular diagnostic solutions, today announced the composition of its supervisory board. William E. Rhodes, III, will be serving as chairman of Curetis' supervisory board (the " Board "), while Mario Crovetto will serve as chairman of Curetis' audit committee. Board members Dr. Werner Schaefer, Dr. Frank Muehlenbeck, Dr. Rudy Dekeyser, and Dr. Holger Reithinger have previously been members of the supervisory board of Curetis AG.

William Rhodes is a healthcare executive with more than 30 years of experience in the healthcare industry, and has been serving as an Operating Partner with Linden Capital Partners' investment team since January 2013. During his 14-year career at Becton, Dickinson and Company (BD, 1998-2012), Mr. Rhodes was an Executive Officer and held several senior leadership positions, including roles as Worldwide President of BD Biosciences (2009-2011). He was responsible for BD's corporate M&A activities as well as leading and growing operating companies. Furthermore, he founded BD Ventures, the venture capital arm of Becton, Dickinson and Co. Prior to Becton Dickinson, he held senior business development positions at Johnson & Johnson and Pfizer Inc. Mr. Rhodes also has served, among other roles, as President of The William-James Co. and has a track record of more than 20 successful acquisitions and divestitures. Mr. Rhodes holds a Master's degree in International Business from Seton Hall University and a BSc degree from Cornell University.

Mario Crovetto has been working as an independent advisor on M&A and corporate projects, notably integrations, divestments and financing since 2011. From 1999 to 2011, he was the CFO of Eurand NV (Specialty Pharmaceuticals), which he took public on NASDAQ in 2007. From 1990 to 1999, he held various senior business positions at Recordati (Pharma-ceuticals), including VP of Corporate Development, Division Manager of Diagnostics and CFO. Prior to that, he worked in various positions at Montedison (Speciality Chemicals), Digital Equipment Corporation, Mobil and SIAR (Management Consulting). Mr. Crovetto holds a BSc in Economics from the Università Cattolica del Sacro Cuore, Milan, and a Master's degree in Business Economics from Harvard University, Cambridge, MA.

"We are very happy to have won two leading, seasoned experts with tremendous experience in the diagnostics industry and capital markets for our Board," said Oliver Schacht, PhD, CEO of Curetis. "Both bring long-standing expertise in business development in the diagnostics and the pharma industry."

"It is a great pleasure for me to join the Board of Curetis," said William Rhodes, Operating Partner with Linden Capital Partners. "Experts all over the world agree that fast, early and reliable diagnosis of pathogens and antibiotic resistance is key for better antibiotic stewardship, and Curetis has developed a very innovative approach to provide a solution for this pressing problem."

Disclaimer

CAUTION - Investigational device. Limited by Federal (or United States) law to investigational use. The information contained in this communication does not constitute nor imply an offer to sell or transfer any product, and no product based on the Curetis Unyvero technology is currently available for sale in the United States of America or Canada. The analytical and clinical performance characteristics of any Curetis Unyvero product which may be sold at some future point in time in the U.S. have not yet been established.

_______________________________ 1 Curetis B.V. will be converted into Curetis N.V.

About the Unyvero Platform

The CE-marked Unyvero System is a versatile hardware platform for the detection of a broad panel of bacteria, fungi and antibiotic resistance genes from a single sample in one run. It processes a disposable Application Cartridge providing the necessary reagents to complete the analysis from sample to result. It is marketed in Europe, Russia, the Middle East and various other non-European countries. In the U.S., Curetis is running a prospective multi-center clinical trial aimed at achieving FDA clearance registered here .

The platform enables the DNA-based testing of all clinically relevant samples in a fully automated, unsupervised analysis process requiring only a few, quick manual preparation steps. The analysis thus can be performed with minimal operator time and without the need of skilled staff or special infrastructure. Thereby, clinically relevant information is available within about four to five hours to support an informed therapy decision as early as possible.

The CE-marked Unyvero P55 Application Cartridge focuses on pneumonia testing and simultaneously analyzes 40 DNA targets. The second CE-marked Unyvero i60 ITI Application Cartridge for implant and tissue infections is also commercially available in Europe and is currently being evaluated in a prospective European multi-center cohort study in prosthetic joint infections (EPJIC) .

Application Cartridges for additional indications are in various stages of development and preparation.

For further information, please visit www.unyvero.com .

About Curetis AG

Founded in 2007, Curetis AG is a molecular diagnostics company which focuses on the development and commercialization of reliable, fast and cost-effective products for diagnosing severe infectious diseases. The diagnostic solutions of Curetis AG enable rapid multi-parameter pathogen and antibiotic resistance marker detection in only a few hours, a process that today can take up to days or even weeks with other techniques.

To date, Curetis AG has raised total funds of over EUR 63.5 million (>US$ 70 million). The company is based in Holzgerlingen near Stuttgart, Germany. Curetis AG has signed collaboration agreements with Heraeus Medical and Cempra Inc. as well as several international distribution agreements covering many countries across Europe, the Middle East and Asia.

For further information, please visit www.curetis.com .

Important legal information

This document may contain forward-looking statements. These statements are based on the current views, expectations and assumptions of the management of Curetis and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. You can identify forward-looking statements by terms such as "believe", "anticipate", "expect", "estimate", "may", "could", "should", "would", "will", "intend", "plan", the negative of such terms or other similar expressions. Actual results, performance or events may differ materially from those described in such statements due to, among other things, changes in the general economic and competitive environment, risks associated with capital markets, currency exchange rate fluctuations and competition from other companies, changes in international and national laws and regulations, rapid technological and market change in the industries Curetis operates in, as well as many other risks specifically related to Curetis and its operations. Curetis does not assume any obligations to update any forward-looking statements.  

Curetis AG Max-Eyth-Str. 42 71088 Holzgerlingen, Germany Tel. +49 7031 49195-10 www.curetis.com - www.unyvero.com International Media Inquiries akampion Dr. Ludger Wess / Ines-Regina Buth Managing Partners Tel. +49 40 88 16 59 64 Tel. +49 30 23 63 27 68 U.S. Media Inquiries The Ruth Group Lee Roth Tel. +1 646 536 7012

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Align Wagner Collection Tests Men's Footwear Depth

Updated Category News Views 18

Three pairs of shoes are not a revolution, but they can expose whether a young brand has its footing. Align, established in 2025 by H.H. Brown, is rolling out the Wagner collection for Fall-Winter 2026 with a waterproof boot, a penny loafer and a lace-up oxford. That is a sensible little arsenal, not some overstuffed catalog dreamed up by a marketing committee that has...

Continue Reading
Subsplash Builds a Broader Church Software Stack in 2026

Updated Category News Views 54

Church software has spent too many years behaving like a junk drawer, and Subsplash is plainly trying to replace it with one working system. The company used its November 18 Product Event in Dallas to show off releases from 2026 and preview two additions: Communications, due in December, and Subsplash Intelligence, targeted for early 2027. A Serious Push Beyond the Church...

Continue Reading
Danaher and Microsoft Put AI Into the Lab Stack Early

Updated Category News Views 39

Laboratory AI gets interesting only when it reaches the hardware bench, and Danaher is taking a serious swing at that ugly, complicated job with Microsoft. The Nov. 20 partnership is not just another chatbot bolted onto a dashboard. It is aimed at building a common agentic platform that can help instruments interpret scientific intent, guide setup, control hardware within...

Continue Reading
Tigerlily Brings HIV Information to Women’s Health

Updated Category News Views 11

A stubborn information gap is exactly where Tigerlily Foundation is planting its flag. The nonprofit’s new national HIV education and awareness campaign, THE POWER OF U, expands work that began in breast cancer advocacy into another area where women need clear facts, trusted voices, and room to speak without being shamed for needing answers. This is not a story that...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 28

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading
SQM Investigation Puts Chile Approval Claims on Trial

Updated Category News Views 71

A Regulatory Promise Meets a Rough Earnings Reaction A 5.52% haircut after disappointing quarterly numbers is the sort of thing that makes shareholders stop pretending every loose management comment is harmless. Sociedad Química y Minera de Chile, NYSE:SQM, is facing an investigation by Levi & Korsinsky into public statements concerning regulatory matters, particularly...

Continue Reading
Wenge AI Removes a Small Friction Point for ScienceOra

Updated Category News Views 84

Scientific software rarely loses users because the underlying model is too clever; it loses them because getting through the front door is a nuisance. Wenge AI has addressed that unglamorous problem by adding Google and Apple sign-in options to the international version of ScienceOra, its AI-powered research and decision-support platform. This is not the sort of...

Continue Reading
COP31 Puts China’s Weather-to-Energy Model on View

Updated Category News Views 55

Storm maps are becoming operating manuals, and that is the hard reality behind a November 13 COP31 event in Antalya, Türkiye. The session, “From Early Warning to Energy Action: Pathways for Global Climate Diplomacy and Cooperation,” put China’s effort to tie meteorological intelligence to energy-system decisions under an international spotlight. This is not...

Continue Reading
HVAC’s $383.6 Billion Shift Is About More Than Units

Updated Category News Views 116

Server racks are turning cooling gear into a front-row industrial story, and that deserves more attention than the usual sleepy talk about replacement air conditioners. Frost & Sullivan projects the global HVAC equipment market will reach $383.6 billion by 2031, growing at a 7.0% compound annual rate from 2025. That is a sizable market, sure, but the more interesting...

Continue Reading
SoCalGas Data Program Puts Metering Case Into Focus

Updated Category News Views 43

Buried beneath the usual utility-company polish is a pretty sensible idea: find waste before a customer gets walloped by a bill. SoCalGas says its Advanced Meter Analytics program has helped customers avoid an estimated $11 million in unnecessary natural-gas costs since 2019. That is not a number likely to move Sempra’s earnings by itself, and nobody should pretend...

Continue Reading

Top 5 Most Recently Viewed Articles

Lifeboat Market Growth Drivers & Future Projections 2024-2033

Updated Category News Views 82

Lifeboat Market Growth Drivers & Future Projections Recent market analysis indicates that the global lifeboat market is on a trajectory of significant growth, expected to expand from a valuation of $311.0 million in 2023 to approximately $416.3 million by 2033, at a compound annual growth rate (CAGR) of 3.2%. This upward trend is primarily driven by stringent maritime...

Continue Reading
Envista Holdings Corp: An Insight Into Market Trends

Updated Category News Views 198

Understanding Envista Holdings Corp's Market Dynamics Envista Holdings Corp (NYSE: NVST) has witnessed notable movements in its short interest percentage recently. The figure has seen a decline of 11.19% from the last available report, indicating a shift in market sentiment. Currently, there are approximately 9.10 million shares sold short, representing 6.67% of the...

Continue Reading
Breakthrough Medical Device Addresses Lipohypertrophy in Diabetes

Updated Category News Views 544

Revolutionizing Diabetes Treatment with Embrace Patch Recent clinical trials have shed light on the embrace Active Site Care compression patch, a pioneering medical device that has demonstrated its efficacy in treating lipohypertrophy (LH) in individuals using insulin for diabetes management. This breakthrough reveals how comprehensive care and innovative technology can...

Continue Reading
Investors' Perspectives on Carpenter Technology Corp's Stock Trends

Updated Category News Views 184

Understanding Carpenter Technology Corp's Short Interest Carpenter Technology Corp (NYSE: CRS) has seen a significant shift in its short interest as a percentage of float, which has decreased by 18.6% since its last report. According to the latest data from exchanges, the current short interest stands at approximately 2.54 million shares sold short, equating to around...

Continue Reading
Exploring Palantir's Future: Sustainable Growth or a Bubble?

Updated Category News Views 416

Palantir Technologies Inc: A Deep Dive into Its Future Palantir Technologies Inc (NASDAQ: PLTR) is attracting considerable attention from investors and industry watchers alike. Renowned for its cutting-edge AI-driven software solutions, Palantir is at the forefront of transforming both defense and enterprise sectors. Following a remarkable surge of 400% in stock value...

Continue Reading